AssetMark Inc’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13K Buy
28
+15
+115% +$6.31K ﹤0.01% 2356
2026
Q1
$4.91K Sell
13
-8
-38% -$3.43K ﹤0.01% 2575
2025
Q4
$8.98K Buy
21
+13
+163% +$5.66K ﹤0.01% 2245
2025
Q3
$3.58K Sell
8
-15
-65% -$6.79K ﹤0.01% 2443
2025
Q2
$11.2K Buy
23
+5
+28% +$2.85K ﹤0.01% 1933
2025
Q1
$11.1K Buy
18
+4
+29% +$2.27K ﹤0.01% 1830
2024
Q4
$7.42K Sell
14
-1
-7% -$564 ﹤0.01% 1850
2024
Q3
$9.02K Buy
+15
New +$8.5K ﹤0.01% 1640
2022
Q1
Sell
-2
Closed -$1K 1563
2021
Q4
$1K Hold
2
﹤0.01% 1417
2021
Q3
$1K Buy
+2
New +$943 ﹤0.01% 1309
2021
Q2
Sell
-2
Closed -$1K 1343
2021
Q1
$1K Buy
+2
New +$980 ﹤0.01% 1224
2020
Q2
Sell
-43
Closed -$19K 1280
2020
Q1
$19K Sell
43
-8,371
-99% -$3.74M ﹤0.01% 878
2019
Q4
$3.7M Buy
8,414
+8,371
+19,467% +$3.52M 0.03% 272
2019
Q3
$18K Hold
43
﹤0.01% 896
2019
Q2
$16K Hold
43
﹤0.01% 913
2019
Q1
$14K Sell
43
-8
-16% -$2.46K ﹤0.01% 939
2018
Q4
$14K Hold
51
﹤0.01% 946
2018
Q3
$16K Hold
51
﹤0.01% 968
2018
Q2
$16K Hold
51
﹤0.01% 970
2018
Q1
$14K Sell
51
-190
-79% -$50.3K ﹤0.01% 986
2017
Q4
$59K Sell
241
-2,196
-90% -$499K ﹤0.01% 738
2017
Q3
$492K Buy
2,437
+2,406
+7,761% +$473K 0.01% 356
2017
Q2
$6K Sell
31
-18
-37% -$3.58K ﹤0.01% 1080
2017
Q1
$9K Sell
49
-3
-6% -$523 ﹤0.01% 986
2016
Q4
$8K Buy
52
+1
+2% +$147 ﹤0.01% 998
2016
Q3
$7K Buy
+51
New +$7.1K ﹤0.01% 1009

Other funds holding CHE

AssetMark Inc's CHE Position: Q2 2026 in Review

AssetMark Inc increased its Chemed (CHE) stake by 115% in Q2 2026, buying an estimated $6.31K and bringing the position to 28 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #2356.

AssetMark Inc first reported a position in CHE in Q3 2016 and has held it in 26 quarters since. The position peaked at $3.7M in Q4 2019. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • AssetMark Inc held 28 shares of Chemed worth $13K as of Q2 2026.
  • AssetMark Inc bought 15 Chemed shares in Q2 2026, an estimated $6.31K.
  • Chemed made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2356 holding.
  • AssetMark Inc first reported a position in Chemed in Q3 2016 and has held it in 26 quarters since.
  • AssetMark Inc's Chemed position peaked at $3.7M in Q4 2019.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.